<- Go home

Added to YB: 2025-01-07

Pitch date: 2025-01-06

SRT.F [bullish]

Sartorius Aktiengesellschaft

+6.5%

current return

Author Info

No bio for this author

Company Info

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers.

Market Cap

EUR 11.7B

Pitch Price

EUR 177.85

Price Target

N/A

Dividend

0.39%

EV/EBITDA

21.83

P/E

154.33

EV/Sales

4.91

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
Sartorius Q4 2024: JPMorgan Forecasts Solid Revenue Growth and Profitable EBITDA Performance

SRT.F: JPM expects €705m BPS orders in Q4'24 (+14% QoQ), driven by strong consumables demand offsetting weak equipment orders. Forecasts solid CER revenue growth, profitable EBITDA growth for 2025. Places SRT/DIM on Positive Catalyst Watch for Q4 results (Jan 28), expecting EBITDA beat & achievable 2025 guidance.

Read full article (2 min)